MedPath

Cognitive Control Training for Remitted Depressed Patients

Not Applicable
Completed
Conditions
Major Depression in Remission
Interventions
Behavioral: Cognitive Control Training
Behavioral: Low Cognitive Load Training
Registration Number
NCT02407652
Lead Sponsor
University Ghent
Brief Summary

The purpose of this study is to explore the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients.

Detailed Description

Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD samples. Furthermore, studies exploring the potential of cognitive control training in at-risk undergraduate students indicate that cognitive control training has beneficial effects on rumination, an important vulnerability factor for depression. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients. The investigators will explore effects on depressive symptomatology, (mal-)adaptive emotion regulation (directly following training and at 3 months follow-up), and indices of functioning (at 3 months follow-up).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • History of ≥ 1 depressive episode(s)
  • Currently in stable full or partial remission (≥ 6 months)
Exclusion Criteria
  • Major depressive disorder (MDD; current)
  • Bipolar disorder (current and/or previous)
  • Psychotic disorder (current and/or previous)
  • Neurological impairments (current and/or previous)
  • Excessive substance abuse (current and/or previous)
  • No other comorbid disorders (current)
  • No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency less than once / 3 weeks)
  • Use of antidepressant medication is allowed if kept at a constant level

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
cognitive control trainingCognitive Control Traininginternet-delivered, 2 weeks
low cognitive load trainingLow Cognitive Load Traininginternet-delivered, 2 weeks
Primary Outcome Measures
NameTimeMethod
Change in depressive rumination from baseline to the post-training assessment and follow-up (RRS)baseline, 2 weeks, 3 months

Assessed using the Ruminative Response Scale (RRS)

Change in depressive symptomatology from baseline to the post-training assessment and follow-up (BDI-II)baseline, 2 weeks, 3 months

Assessed using the Beck Depression Inventory (BDI-II)

Secondary Outcome Measures
NameTimeMethod
Resilience (RS)baseline, 3 months

Assessed using the Resilience Scale (RS)

Quality of Life (QLDS)baseline, 3 months

Assessed using the Quality of Life in Depression Scale (QLDS)

Disability (WHODAS 2.0)baseline, 3 months

Assessed using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

(mal-)Adaptive cognitive emotion regulation (CERQ)baseline, 2 weeks, 3 months

Assessed using the Cognitive Emotion Regulation Questionnaire (CERQ)

Remission from depression (RDQ)baseline, 3 months

Assessed using the Remission of Depression Questionnaire (RDQ)

Trial Locations

Locations (1)

Ghent University

🇧🇪

Ghent, Oost-Vlaanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath